Introduction
============

Among the patients admitted to intensive care units (ICUs), those requiring ventilator care consume high amounts of medical resources and incur much expense[@B1][@B2]. Several studies have suggested that an important factor contributing to the high cost of health care may be associated with the clinician decision-making at the patient\'s bedside[@B3][@B4][@B5][@B6]. Accordingly, the length of stay of a patient in the ICU would be expected to be longer, and it may be helpful for critical-care physicians to determine at an early stage if these patients would really benefit from ICU care.

Recently, some reports described a novel subpopulation of patients on mechanical ventilation (MV): those who require MV for ≥96 hour, referred to as \"prolonged acute mechanical ventilation\" (PAMV) cases[@B2][@B7][@B8][@B9]. These studies reported that PAMV patients constituted one-third of all hospitalized patients undergoing MV and consumed two thirds of the medical resources of all MV patients[@B2][@B7][@B8][@B9]. Also, these patients are projected to increase in the years to come[@B7][@B8]. Thus, further research needs to focus on more accurately characterizing the clinical outcomes and prognostic factors for such patients.

When critical care physicians discuss and guide the goal of care and prognosis of PAMV patients, a mortality prediction model would be necessary to address prognostic uncertainty. Although clinical parameters on their clinical course would be associated with clinical outcomes, the concurrent comorbidities before admission should be considered. In the existing literature, Charlson\'s weighted index of comorbidities (WIC) has been suggested to have a predictive value[@B10] and has also been shown to predict hospital mortality in critically ill patients[@B10][@B11][@B12][@B13][@B14]. In existing literature, there were some reports about the validity and utility of Charlson\'s WIC in relation to other illness scores (such as Acute Physiology and Chronic Health Evaluation \[APACHE\] II and Sequential Organ Failure Assessment \[SOFA\] scores) in predicting the outcome of critically ill patients[@B11][@B12][@B13][@B14][@B15][@B16]. Based on previous reports, we hypothesized the role of this index as a prognostic model for PAMV population.

This study sought to investigate the prognostic value of Charlson\'s WIC in predicting 60-day mortality after MV in patients defined as PAMV cases in a medical ICU of a university-affiliated tertiary care center in South Korea.

Materials and Methods
=====================

1. Study design
---------------

This retrospective study was conducted in Pusan National University Hospital, Republic of Korea, a university-affiliated tertiary care hospital with a 12-bed medical ICU with full cardiovascular and close airway monitoring as well as a separate seven-bed adult coronary care unit. The physician staff in the medical ICU consisted of one full-time specialist, one clinical fellow in pulmonary and critical care medicine, two resident physicians, and one intern. Fellows and resident physicians provided overnight care, and the nurse-to-bed ratio was 1:3. Full-time physical and respiratory rehabilitation therapies were available for all patients. Consultation services were accessible for all the subspecialists in the hospital. All patients were managed according to therapeutic recommendations based on early goal-directed therapy and a lung-protective ventilator strategy[@B17][@B18].

2. Study subjects
-----------------

Patients defined as PAMV cases within the period from March 1, 2008, to February 28, 2013 were included in this study. The PAMV patients were those who had undergone MV for longer than 4 days in the ICU[@B2], regardless of tracheostomy. The exclusion criteria included patients younger than 18 years who received ventilator care prior to ICU admission. The medical records and laboratory and radiological findings of all the patients were reviewed. The investigators completed a case report form, and data were collected from March to June 2014. The three investigators (S.E.S., S.H.L., and K.L.) confirmed that the study objectives and procedures were honestly disclosed, and all had full access to all the study data. This study was conducted with approval from the Institutional Review Board of Pusan National University Hospital (E-2015127). This study had no impact on the patient treatment.

3. Data collection
------------------

The following data were gathered from the medical records of each patient: age, gender, body mass index, presence of shock on the ICU admission day, duration of MV, and length of stay in the ICU and hospital. The ICU and in-hospital mortality for all the patients were recorded. The APACHE II and SOFA scores were calculated to quantify the severity of the illness and the degree of organ dysfunction, respectively, using the data from the first 24 hours of ICU admission[@B15][@B16]. Charlson\'s WIC, acquired from the medical records of all the patients\' comorbidities before the catastrophic illness requiring ICU care, was calculated to predict the effect of the underlying diseases on the patient outcomes[@B10]. The major diagnoses leading to MV were also collected. We also evaluated the do-not-resuscitate (DNR) status records of the patients within 4 days after ICU admission. The survivors were defined as patients who had survived for 60 days after ICU admission.

4. Statistical analysis
-----------------------

The continuous variables were expressed as median values with the range or mean±standard deviation, and the categorical variables were expressed as numbers (percentages). Student\'s t test and Mann-Whitney U test were used to compare the continuous variables, and the chi-square and Fisher exact tests (for small numbers) were used to compare the categorical variables. To evaluate the relationship between WIC and the other clinical variables, the Pearson\'s correlation coefficient (γ) was calculated. Receiver operating characteristic (ROC) curves and the area under the curve (AUC) were used. Univariate Cox proportional hazard models were developed to determine the relationship between WIC and mortality. Variables with p\<0.05 were included in the multivariate Cox proportional hazard model. Survival curves were prepared using the Kaplan-Meier method with the log-rank test. All the statistical analyses were performed using the Statistical Package for the Social Sciences (version 19.0, IBM Corp., Armonk, NY, USA) program. A two-tailed p-value \<0.05 was considered to indicate a significant difference.

Results
=======

A total of 754 patients who had been admitted to the medical ICU and to whom MV was applied during the study period were identified. Among them, 311 patients (41.2%) met the definition of PAMV. Among these patients, 12 patients (3.9%) had DNR order given before day 4 of MV. We appropriately excluded them because this would be effective modified of prognosis. For the total enrolled patients (n=299), the ICU and in-hospital mortality rates were 41.5 and 42.1%, respectively. In addition, the 60-day mortality rate after ICU admission was 35.5%. [Table 1](#T1){ref-type="table"} shows the results of the baseline characteristics of all enrolled patients, and the results of the comparisons between the survivors and the nonsurvivors.

The enrolled patients had an average WIC of 2.3±1.8 and a median WIC of 2 (range, 0--11). The number of patients for each WIC level and the corresponding mortality are shown in [Figure 1](#F1){ref-type="fig"}. Results of the investigation of all the components of WIC and their matching patients are shown in [Table 2](#T2){ref-type="table"}. [Table 2](#T2){ref-type="table"} also shows the comparisons between survivors and nonsurvivors according to the components of WIC.

When the relationship between WIC and the clinical variables upon admission were analyzed, it was found that the WIC score was positively correlated with the APACHE II (γ=0.321, p\<0.001) and SOFA (γ=0.224, p\<0.001) scores on admission day, respectively.

When the WIC scores of the nonsurvivors and survivors were compared, it was found that the nonsurvivors had significantly higher WIC scores than the survivors (2.7±2.1 vs. 2.1±1.7, p=0.008). The AUC of the ROC curve for WIC in our cohort was 0.592 (95% confidence interval, 0.523--0.661; p=0.008). Kaplan-Meier curves of 60-day survival are shown in [Figure 2](#F2){ref-type="fig"}. Survival curves showed WIC ≥5 had statistically significant differences than other WIC scores (log-rank test, p=0.027). In a univariate Cox proportional hazard model, four clinical factors were associated with poor prognosis (p\<0.05): WIC more than or equal to 5; presence of shock on ICU admission day; acute respiratory distress syndrome (ARDS) on ICU admission day; and APACHE II score of more than or equal to 17 (the cut-off level was determined by ROC curves).

After adjusting for age and sex, these factors were included in a multivariate model: 3 factors (WIC ≥5, ARDS on ICU admission day, and APACHE II ≥17) were independently associated with the 60-day mortality ([Table 3](#T3){ref-type="table"}). The mortality rate of patients with WIC ≥5 was 54.2%.

Discussion
==========

The previous studies have shown that comorbid conditions before admission appear to predict mortality in ICU patients, and as such, comorbidity indices should be used as an important tool for predicting patient outcomes[@B11][@B19][@B20][@B21]. In the present study, the prognostic value of Charlson\'s WIC in PAMV patients was investigated. It was demonstrated that a WIC score of more than or equal 5 was associated with the increased 60-day mortality of our enrolled patients. Based on the present study results, a higher WIC score might be helpful in predicting the mortality of PAMV patients.

In this study, however, the AUC of the ROC curve for the WIC score was lower and the WIC score had weak correlation with the APACHE II and SOFA score. Moreover, as shown in [Figure 2](#F2){ref-type="fig"}, we could not find the prognostic value in a WIC score less than 4 in predicting 60-day mortality. Also, we could not find how each component of WIC could affect their prognosis. Although our result suggests that WIC may be a useful indicator to assist physicians in decisions related to patient management and counseling with their families or surrogates, this index should not override clinical judgments. In addition, our study was a single center experience. Further research is needed to determine the influence of comorbidities on the prognosis of these patients.

Based on the previous reports[@B2][@B7][@B8][@B9], the incidence of PAMV cases seems likely to increase in the future, making it an emerging challenge for the critical-care delivery system. In the Asian ICUs (including those in South Korea), however, the critical-care resources and facilities of university hospitals are typically limited compared to those of the developed countries in North America and Europe[@B22][@B23]. In addition, a shortage of critical-care personnel, including full-time intensivists, and a low nurse-to-patient ratio, exist, which are serious issues for clinical practice[@B24]. Accordingly, a prediction model that identifies patients with poor or good risks for clinical course may be useful for informing the discussions among the clinicians and the patients\' families (or surrogates). Although there were reported data about the prognostic factors for these patients[@B25], developing a new mortality model through a large-scale multicenter study would be necessary for the South Korean patient population requiring PAMV.

This study had several limitations. First, it was conducted retrospectively, which may have resulted in an informational bias. Second, the study was an observational retrospective analysis, and our data represent the experience of a single center. Thus, the results of our study may not represent the general situation in Korea. Third, our study was a retrospective one, we could not know how to deal with some patients who were not already indicated in the ICU but could not be out of the ICU because there was no general ward vacancy or availability in other hospitals. Fourth, in our results, the mortality of patients with WIC=0 was higher than that of patients with WIC=1 or 2. Because our study was retrospective study, all patients\' various comorbidities could be omitted in medical records, and all comorbidities could not gathered completely.

In conclusion, this study investigated the usefulness of Charlson\'s WIC as a prognostic indicator in PAMV patients. It was found that higher WIC scores than that of the survivors, and WIC ≥5 might be helpful in predicting 60-day mortality. In terms of identifying a prognostic value of this score in PAMV, this population is set to increase so prospective, large-scale, multicenter studies with longer follow-up time periods are required to determine if this index can be considered a prognostic factor.
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###### Comparison of baseline characteristics between survivors and nonsurvivors

![](trd-79-289-i001)

  Characteristic                     Total (n=299)   Survivor (n=193)   Nonsurvivor (n=106)   p-value
  ---------------------------------- --------------- ------------------ --------------------- ---------
  Age, yr                            65.1±14.1       64.0±14.1          67.2±14.1             0.058
  Male                               211 (70.6)      133 (68.9)         78 (73.6)             0.428
  Body mass index, kg/m^2^           21.7±4.0        21.9±3.6           21.3±4.6              0.219
  ICU LOS, day                       21.9±19.7       24.7±22.8          16.9±10.6             \<0.001
  Hospital LOS, day                  39.4±39.1       49.0±44.9          22.0±14.0             \<0.001
  APACHE II score on admission day   17.1±6.0        16.5±5.9           18.1±6.1              0.028
  SOFA score on admission day        4.9±2.5         4.9±2.5            5.0±2.7               0.921
  Total MV days                      17.9±19.5       19.2±22.9          15.6±10.4             0.130
  Shock on admission day             223 (74.6)      138 (71.5)         85 (80.2)             0.126
  Major diagnosis leading to MV                                                               
   Pneumonia without ARDS            148 (49.5)      97 (50.2)          51 (48.1)             0.809
   Pneumonia with ARDS               59 (19.7)       16 (8.3)           43 (40.6)             \<0.001
   Cardiogenic pulmonary edema       55 (18.4)       48 (24.9)          7 (6.6)               \<0.001
   Aspiration                        20 (6.7)        17 (8.8)           3 (2.8)               0.054
   AE of chronic lung diseases^\*^   17 (5.7)        15 (7.8)           2 (1.9)               0.038

Values are presented as mean±standard deviation or number (%).

^\*^Chronic lung diseases: chronic obstructive pulmonary disease, asthma, and bronchiectasis.

ICU LOS: intensive care unit length of stay; APACHE: Acute Physiology and Chronic Health Evaluation; SOFA: Sequential Organ Failure Assessment; MV: mechanical ventilation; ARDS: acute respiratory distress syndrome; AE: acute exacerbation.

###### Comparison of the components of Charlson\'s weighted index of comorbidities between survivors and nonsurvivors
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  Assigned weight for underlying disorder   Underlying disorder                   Total (n=299)   Survivor (n=193)   Nonsurvivor (n=106)   p-value
  ----------------------------------------- ------------------------------------- --------------- ------------------ --------------------- ----------------
  1                                         Myocardial infarction                 16 (5.4)        5 (2.6)            11 (10.4)             0.006
                                            Congestive heart failure              54 (18.1)       35 (18.1)          19 (17.9)             \>0.999
                                            Peripheral vascular disease           5 (1.7)         5 (2.6)            0 (0)                 0.165
                                            Cerebrovascular disease               70 (23.4)       49 (25.4)          21 (19.8)             0.319
                                            Dementia                              9 (3.0)         6 (3.1)            3 (2.8)               \>0.999
                                            Chronic pulmonary disease             124 (41.5)      75 (38.9)          49 (46.2)             0.223
                                            Connective tissue disease             19 (6.4)        16 (8.3)           3 (2.8)               0.082
                                            Ulcer disease                         22 (7.4)        15 (7.8)           7 (6.6)               0.819
                                            Mild liver disease                    23 (7.7)        16 (8.3)           7 (6.6)               0.658
                                            Diabetes                              69 (23.1)       45 (23.3)          24 (22.6)             \>0.999
  2                                         Hemiplegia                            16 (5.4)        13 (6.7)           3 (2.8)               0.186
                                            Moderate and severe renal disease     39 (13.0)       19 (9.8)           20 (18.9)             0.032
                                            Diabetes with end-organ damage        15 (5.0)        9 (4.7)            6 (5.7)               0.784
                                            Any tumor                             37 (12.4)       15 (7.8)           22 (20.8)             0.002
                                            Leukemia                              1 (0.3)         1 (0.5)            0 (0.0)               \>0.999
                                            Lymphoma                              1 (0.3)         1 (0.5)            0 (0.0)               \>0.999
  3                                         Moderate and severe liver disease     11 (3.7)        4 (2.1)            7 (6.6)               0.058
  6                                         Metastatic tumor                      6 (2.0)         3 (1.6)            3 (2.8)               0.670
                                            Acquired immune deficiency syndrome   0 (0)           0 (0)              0 (0)                 Not applicable

Value are presented as number (%).

###### Multivariate analysis of factors associated with 60-day mortality
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  Factor                                   Multivariate analysis   
  ---------------------------------------- ----------------------- ---------
  Presence of shock on ICU admission day   1.199 (0.739--1.946)    0.462
  ARDS on ICU admission day                4.527 (3.039--6.743)    \<0.001
  APACHE II ≥17                            1.601 (1.075--2.385)    0.021
  WIC ≥5                                   1.901 (1.140--3.171)    0.014

Statistical significance was tested by multivariate Cox hazards models.

HR: hazard ratio; CI: confidence interval; ICU: intensive care unit; ARDS: acute respiratory distress syndrome; APACHE: Acute Physiology and Chronic Health Evaluation; WIC: Charlson\'s weighted index of comorbidities.
